PDCD1 and cancer: Additionally, studies have shown that the immune checkpoint receptor of PD-L1, namely, programmed cell death 1 (PD-1), which is primarily expressed on T cells, monocytes, macrophages, and natural killer cells, could be a critical negative regulator of cancer biology and may have the ability to support cancer development, growth, invasion, and metastasis [7].